Nathan Touati
About
Nathan Touati is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine.
According to data from OpenAlex, Nathan Touati has authored 19 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Nathan Touati's work include Sarcoma Diagnosis and Treatment (11 papers), Vascular Tumors and Angiosarcomas (4 papers) and Cardiac tumors and thrombi (4 papers). Nathan Touati is often cited by papers focused on Sarcoma Diagnosis and Treatment (11 papers), Vascular Tumors and Angiosarcomas (4 papers) and Cardiac tumors and thrombi (4 papers). Nathan Touati collaborates with scholars based in Belgium, United Kingdom and France. Nathan Touati's co-authors include Saskia Litière, Alessandro Gronchi, Hans Gelderblom, Sandrine Marréaud, Silvia Stacchiotti, Bernd Kasper, Winette T.A. van der Graaf, Stefan Sleijfer, Florence Duffaud and Paolo G. Casali and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Cancer Research.
In The Last Decade
Nathan Touati
17 papers receiving 497 citations
Peers
Nathan Touati
C. Piovesan Italy
Geraldine Goss Australia
Olfa Derbel France
Daniela Katz Israel
P. Chalabreysse France
Auxiliadora Gómez‐España Spain
Nasim Ali United Kingdom
Rashpal Flora United Kingdom
K.N. Price Switzerland
Elena Bellan Italy
Citations per year, relative to Nathan Touati Nathan Touati (= 1×)
peers
C. Piovesan
Countries citing papers authored by Nathan Touati
Since
Specialization
Citations
This map shows the geographic impact of Nathan Touati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Touati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Touati more than expected).
Fields of papers citing papers by Nathan Touati
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Nathan Touati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Touati. The network helps show where Nathan Touati may publish in the future.
Co-authorship network of co-authors of Nathan Touati
This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Touati. A scholar is included among the top collaborators of Nathan Touati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Touati. Nathan Touati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Jones, D. I., Marco Carbone, Andreas E. Kremer, et al.. (2025). LBP-027 Elafibranor improves fatigue versus placebo in patients with primary biliary cholangitis, with limited correlation with pruritus: analyses from the phase III ELATIVE® trial. Journal of Hepatology. 82. S83–S84.
2.
Karch, André, et al.. (2024). P892 Do anti TNF alpha drugs reduce cardiovascular risk in Crohn's disease ?. Journal of Crohn s and Colitis. 18(Supplement_1). i1630–i1630.
3.
Mir, Olivier, Nathan Touati, Michela Lia, et al.. (2019). Impact of Concomitant Administration of Gastric Acid–Suppressive Agents and Pazopanib on Outcomes in Soft-Tissue Sarcoma Patients Treated within the EORTC 62043/62072 Trials. Clinical Cancer Research. 25(5). 1479–1485.
4.
Vos, Melissa, Stefan Sleijfer, Saskia Litière, et al.. (2019). Association of pazopanib-induced toxicities with outcome of patients with advanced soft tissue sarcoma; a retrospective analysis based on the European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 clinical trials. Acta Oncologica. 58(6). 872–879.
5.
Pasquali, Sandro, Sara Pizzamiglio, Nathan Touati, et al.. (2019). The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial. European Journal of Cancer. 109. 51–60.
6.
Italiano, Antoîne, Nathan Touati, Saskia Litière, et al.. (2018). Prospective assessment of the predictive value of the BRCA1 gene status in sarcoma patients treated with trabectedin: an updated analysis of the EORTC 62091 trial. Cancer Medicine. 7(5). 1575–1577.
7.
Aalders, K.C., Nathan Touati, Konstantinos Tryfonidis, et al.. (2018). Do patients whose tumor achieved a pathological response relapse at specific sites? A substudy of the EORTC 10994/BIG-1-00 trial. Breast Cancer Research and Treatment. 169(3). 497–505.
8.
Wildiers, Hans, Konstantinos Tryfonidis, Lissandra Dal Lago, et al.. (2018). Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group. The Lancet Oncology. 19(3). 323–336.
9.
Touati, Nathan, P. Schöffski, Saskia Litière, et al.. (2018). European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Experience with Advanced/Metastatic Epithelioid Sarcoma Patients Treated in Prospective Trials: Clinical Profile and Response to Systemic Therapy. Clinical Oncology. 30(7). 448–454.
10.
Pasquali, Sandro, Sara Pizzamiglio, Nathan Touati, et al.. (2018). The Impact of Chemotherapy on Survival of Patients with Extremity and Trunk Wall Soft Tissue Sarcoma: Revisiting the Results of the EORTC-STBSG 62931 Randomised Trial Using Sarculator, a Validated Nomogram-Based Risk Assessment Tool. SSRN Electronic Journal.
11.
D’Ambrosio, Lorenzo, Nathan Touati, Jean‐Yves Blay, et al.. (2018). Doxorubicin plus dacarbazine (DoDa), doxorubicin plus ifosfamide (DI) or doxorubicin alone (Do) as first line treatment for advanced leiomyosarcoma (LMS): A retrospective study from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG).. Journal of Clinical Oncology. 36(15_suppl). 11574–11574.
12.
Pasquali, Sandro, Sara Pizzamiglio, Nathan Touati, et al.. (2018). Prognostic stratification using the nomogram sarculator and its impact on study results in a randomized controlled trial (RCT) for localized soft tissue sarcomas (STS): A secondary analysis of the EORTC-STBSG 62931.. Journal of Clinical Oncology. 36(15_suppl). 11518–11518.
13.
Touati, Nathan, et al.. (2017). Factors predictive of locoregional recurrence following neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancer: An analysis of the EORTC 10994/BIG 1-00 study. European Journal of Cancer. 79. 226–234.
14.
Touati, Nathan, Patrick Schöffski, Saskia Litière, et al.. (2017). EORTC experience with advanced/metastatic epithelioid sarcoma patients treated in prospective trials: Clinical profile and response to systemic therapy. Annals of Oncology. 28. v528–v528.
15.
Touati, Nathan, Saskia Litière, Stefan Sleijfer, et al.. (2017). Evolution in neutrophil-to-lymphocyte ratio (NLR) among advanced soft tissue sarcoma (STS) patients treated with pazopanib within EORTC 62043/62072 trials. Annals of Oncology. 28. v531–v531.
16.
Touati, Nathan, Konstantinos Tryfonidis, Franco Caramia, et al.. (2016). Correlation between severe infection and breast cancer metastases in the EORTC 10994/BIG 1-00 trial: Investigating innate immunity as a tumor suppressor in breast cancer. Annals of Oncology. 27. vi79–vi79.
17.
Touati, Nathan, Konstantinos Tryfonidis, Franco Caramia, et al.. (2016). Correlation between severe infection and breast cancer metastases in the EORTC 10994/BIG 1-00 trial: Investigating innate immunity as a tumour suppressor in breast cancer. European Journal of Cancer. 72. 95–102.
18.
Kollár, Attila, Robin L. Jones, Silvia Stacchiotti, et al.. (2016). Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis. Acta Oncologica. 56(1). 88–92.
19.
Touati, Nathan, et al.. (2013). Peripheral paraneoplastic neuropathy, an uncommon clinical onset of sigmoid cancer. Journal of the Neurological Sciences. 333. e686–e686.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by C. Piovesan Breakdown of academic impact, for papers by Geraldine Goss Breakdown of academic impact, for papers by Olfa Derbel Breakdown of academic impact, for papers by Daniela Katz Breakdown of academic impact, for papers by P. Chalabreysse Breakdown of academic impact, for papers by Auxiliadora Gómez‐España Breakdown of academic impact, for papers by Nasim Ali Breakdown of academic impact, for papers by Rashpal Flora Breakdown of academic impact, for papers by K.N. Price Breakdown of academic impact, for papers by Elena Bellan